Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1715 of 6351
-
Brain zaps plus brain games show promise for dementia
Symptom relief Recruiting nowDementia is a prevalent condition with no known cure. It affects not only the person with dementia but also the family. This study will investigate the effects of applying different transcranial electrical stimulation (tES) waveforms to find the optimal stimulation when paired wi…
Sponsor: University of Manitoba • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New combo pill aims to tackle obesity and diabetes together
Disease control OngoingThe main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate the safety and efficacy of LY3841136 for chronic weight management alone or in combination with Tirzepatide across a wide dose range in participants with Type 2 Diabet…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New depression drug candidate ABX-002 enters Mid-Stage trial
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if ABX-002 added to an existing antidepressant treatment will benefit depression symptoms in adults with moderate to severe major depressive disorder who have had an inadequate response to their antidepressant. This is a double-blind, …
Phase 2 • Sponsor: Autobahn Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden prostate cancer
Diagnosis CompletedThis study is being done to compare how much using Cytalux™ (pafolacianine) with NIR (Near InfraRed) fluorescent imaging improves the detection of malignant (growing in an uncontrolled way) tissue in adult subjects undergoing prostatectomy and lymph node dissection for biopsy con…
Phase 2 • Sponsor: Indiana University • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThe goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity to determine the preliminary recommended dose for expansion (RDE) of NKT3964 in adults with advanced or metastatic solid tumors. T…
Phase 1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New digital tool aims to stop pregnancy pelvic pain from becoming a lifelong problem
Prevention Recruiting nowThe overall aim is to educate women to handle common pregnancy-related pain experiences to facilitate healthy life-long physical activity habits and prevent chronic pain. Our developed WOMENinMOTION model with person-centred preventions and interventions focused on management of…
Sponsor: Vastra Gotaland Region • Aim: Prevention
Last updated Jun 26, 2026 14:24 UTC
-
New drug targets Hard-to-Treat cancers with genetic flaw
Disease control Recruiting nowThe main purpose of this study is to find out whether the study drug, LY4050784, is safe, tolerable and effective in participants alone or in combination with other anticancer agents. In addition, with locally advanced or metastatic solid tumors with a BRG1 (Brahma-related gene 1…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New combo therapy targets tough blood cancers
Disease control Recruiting nowThe purpose of this research is to gather information on the safety and effectiveness determining maximum tolerated dose (MTD) of ruxolitinib in combination with ivosidenib in IDH1-mutated advanced-phase Ph-negative MPNs while evaluate the efficacy of ruxolitinib in combination w…
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could a daily pill replace insulin for kidney transplant patients?
Disease control Recruiting nowBackground: Post-transplant hyperglycaemia occurs frequently in renal transplant recipients within the first two weeks after transplantation. Standard-of-care is primarily based on insulin treatment with the adherent risk of hypoglycaemia and weight gain. Semaglutide produces an …
Phase 4 • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New Ketamine-Like drug could ease nerve pain without the high
Symptom relief Recruiting nowThe goal of this randomized double blind three way (1:1:1) cross over clinical trial is to evaluate the effectiveness and duration of analgesia of a single infusion of (2R,6R)-HNK 0.5mg/kg compared with ketamine 0.5mg/kg and saline with a 5-week interval between treatments on pai…
Phase 1/2 • Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Peer power: new study aims to boost HIV med adherence in women
Disease control Recruiting nowThe goal of this combination Type 1 hybrid and observational study is to evaluate the impact of a peer delivered intervention of acceptance and commitment therapy (ACT) + exercise + social support to address the substance (ab)use, violence, and AIDS/HIV (SAVA) to improve medicati…
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a popular Weight-Loss drug help people with rare genetic obesity?
Disease control Recruiting nowRare genetic forms of obesity, so called monogenic obesity are linked to alteration in energy balance involving hypothalamic pathways. More than 60 genes encoding for proteins located in the hypothalamic leptin/melanocortin pathway have been described in the French National Prot…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug could help High-Risk patients get Life-Saving transplants
Disease control Recruiting nowThis research is being done to investigate the safety and effectiveness of Darzalex Faspro (daratumumab and hyaluronidase-fihj) (a monoclonal antibody that targets plasma cells that make antibodies) and whether it can lower donor specific antibodies (DSA) levels to low enough lev…
Early phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New scan could sharpen liver cancer detection
Diagnosis Recruiting nowThis prospective, single-center study evaluates the clinical utility of F18-Piflufolastat (PSMA) PET/CT when added to conventional cross-sectional imaging for patients with suspected or confirmed hepatocellular carcinoma (HCC). The study aims to determine whether PSMA PET/CT impr…
Sponsor: VA Office of Research and Development • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
New injection could help nasal polyp sufferers avoid surgery
Disease control OngoingThe goal of this clinical trial is to learn if GR1802 works to treat severe chronic rhinosinusitis with nasal polyps (CRSwNP) in adults. It will also learn about the safety of GR1802. The main questions it aims to answer are: 1. Does GR1802 reduce the need for surgery and system…
Phase 3 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New shot aims to stop the maddening itch of prurigo nodularis
Symptom relief Recruiting nowThis trial was designed to evaluate the efficacy and safety of SHR-1819 injection in patients with Prurigo Nodularis.
Phase 2/3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
What happens when you stop Weight-Loss shots? new study tests backup plans
Disease control CompletedThe study compares the effectiveness of treatment options for weight management after discontinuing semaglutide and tirzepatide. The primary outcome is absolute and percentage weight change at 12-weeks.
Phase 4 • Sponsor: WW International Inc • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can mental rehearsal and virtual reality rebuild arm strength after stroke?
Symptom relief CompletedThis study aims to examine the effect of an action simulation circuit training for individuals who have experienced upper extremity weakness following a stroke. The study will also examine the feasibility of the intervention as an occupational therapy rehabilitation approach. Pa…
Sponsor: Towson University • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New drug could reduce need for infusions in nerve disorder
Disease control OngoingThe purpose of this Phase 2 study is to evaluate the safety, tolerability, pharmacometrics, and efficacy of Claseprubart (DNTH103) in participants with multifocal motor neuropathy (MMN).
Phase 2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Gene therapy for rare brain diseases: 5-Year safety check begins
Disease control OngoingThis study is to continue Long-Term Follow-Up of Patients who were previously treated with AXO-AAV-GM2 Gene Therapy as treatment for Tay-Sachs or Sandhoff Disease to follow the subjects through 5 years after their initial gene therapy treatment.
Sponsor: Terence Flotte • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC